ArticleChemMedChem2022

Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS-CoV-2 Papain-Like Protease.

Lennart Brewitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.